Birth defects and neonatal morbidity caused by teratogen exposure after the embryonic period

Angela E Scheuerle1, Arthur S Aylsworth2

  • 1Department of Pediatrics, University of Texas Southwestern Medical Center, Dallas, Texas.

Abstract

Insights

A new list identifies birth defects potentially linked to fetal period drug exposure. This helps pregnancy registries assess risks beyond the first trimester, improving safety for developing babies.

Area of Science:

  • Teratology and developmental toxicology
  • Reproductive and perinatal epidemiology
  • Public health surveillance

Background:

  • Pregnancy registries assess drug exposure risks for congenital anomalies.
  • Most major birth defects arise during early embryogenesis.
  • No standardized list exists for defects potentially caused by fetal period exposures.

Purpose of the Study:

  • To create a standardized list of anomalies potentially caused by drug exposure limited to the fetal period.
  • To aid pregnancy exposure registries in evaluating risks beyond the first trimester.

Main Methods:

  • Utilized a six-digit-code list to identify relevant anomalies.
  • Excluded defects with documented first-trimester pathogenesis, chromosomal, or single-gene disorders.
  • Included defects originating/manifesting post-embryonic period, those with unclear pathogenesis, or growth components.

Main Results:

  • Identified anomalies potentially linked to fetal period teratogen exposure.
  • Included defects like porencephaly, cataracts, club foot, microcephaly, and hemihyperplasia.
  • Included unspecified defects due to insufficient information on embryogenesis.

Conclusions:

  • A comprehensive list of major and minor anomalies across 11 organ systems was developed.
  • This list may be caused by teratogen exposure during the fetal period.
  • Facilitates more accurate risk assessment in pharmaceutical pregnancy exposure registries.

Related Concept Videos

Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
4.4K
Meiosis vs. Mitosis02:57

Meiosis vs. Mitosis

Cell division is necessary for growth and reproduction in organisms. Mitosis aids cell growth and development by dividing somatic cells. In contrast, meiosis causes the division of germ cells and plays an essential role in sexual reproduction. Due to their unique functional requirements, mitosis and meiosis differ from each other in multiple aspects.
Before the start of mitosis and meiosis I, the cell synthesizes DNA, resulting in two homologous copies of each chromosome. DNA synthesis is...
73.5K
Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
1.1K
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
4.2K
Drug Toxicity: Dose-Dependent Reactions01:24

Drug Toxicity: Dose-Dependent Reactions

Drug toxicities can be stratified into pharmacological, pathological, or genotoxic based on their mechanisms. The incidence and severity of these toxicities generally increase with the drug's concentration in the body and exposure time.Pharmacological toxicity is evident when the therapeutic effects of drugs overshoot into adverse reactions in a predictable, dose-dependent manner. Central nervous system (CNS) depression from barbiturates is a classic example, with effects escalating from...
102
Drug Toxicity: Risk factors01:24

Drug Toxicity: Risk factors

Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...
95